Join our Director General Dr Claire Skentelbery at BIO-Europe Spring on the 23rd of March for an afternoon session dedicated to the EU Biotech Act Part […]
Join Director General Sandra Gallina and EuropaBio to explore the EU Biotech Act proposal, published in December 2025. The webinar explores the Goal of the Act, […]
AseBio announces the Green Innovation Forum2026, which will take place in Salamanca on 20–21 April 2026, positioning the city as a meeting point for green biotechnology, […]
Proud to support BioSolutions UK conference — a new platform bringing together leaders in engineering biology to accelerate growth, collaboration and real-world adoption. Biosolutions are reshaping food, agriculture, […]
CEBioForum 2026 is a leading international biotechnology conference bringing together professionals from Central and Eastern Europe and beyond. With over 20 years of tradition, CEBioForum serves […]
Join our Director General Dr Claire Skentelbery in Finland! Join us at the Hanaholmen Cultural Center in Espoo Finland for inspiring talks on Pharma & Diagnostics, […]
BioPharmaChem 2026 will bring together leading business leaders and experts on many pertinent topics including: realising the potential of the ecosystem, sustainability, digitalisation, the power of […]
EuropaBio is supporting EFGCP Conference 2026. Europe is at a defining moment for clinical research. The Clinical Trials Regulation set out a powerful vision: a continent […]
We are thrilled to announce our partnership with the EU Pharmaceutical Law Forum, one of the most significant events for legal and compliance professionals in the pharmaceutical […]
ECRD is the largest, patient-led policy-shaping conference for rare diseases in Europe. The event is an instrumental tool for advancing policy objectives that improve the lives of people […]
EuropaBio is joining Bio Innovations Europe 2026 as a Headline Partner. Taking place on 10-11 June 2026 in The Hague, the event—formerly known as World Bio […]
EuropaBio is a proud sponsor of the European Biotech Forum 2026. Biotechnology is becoming a decisive capability for Europe’s competitiveness, industrial resilience and strategic autonomy. But […]
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
